Biolevox™ HA 2.2%

Product description

Biolevox™ HA is intended for patients with osteoarthritis. Sodium hyaluronate, obtained by bacterial fermentation, improves viscoelastic properties of the synovial fluid in all synovial joints. * High HA concentration 2.2%
* Very high viscoelastic properties 
* Optimal molecular weight 1.5-2.0 mln Da
* Ready to use prefilled syringe
Read more


Categories Finished Dosage FormsInjectables; Pharmaceutical PackagingMedical Devices and Medical Packaging; BiopharmaceuticalsRegenerative Medicine
Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; Africa; Central/South America
Supplied from Poland
Measured In Pieces
Selling Points Bone & Joint Health; Brand Name
Show more specifications

More products from Biovico

Products from other suppliers

Biolevox™ HA 2.2%

Contact information




View all contact information